The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1/2 study of BDC-3042, a novel dectin-2 agonistic antibody, in patients with advanced cancers.
 
Mohamad Adham Salkeni
Employment - Next Oncology; Virginia Cancer Specialists
Stock and Other Ownership Interests - Next Oncology
Honoraria - Healthcasts
Research Funding - 1ST Biotherapeutics (Inst); Agenus (Inst); BeiGene (Inst); Boehringer Ingelheim (Inst); Bolt Biotherapeutics (Inst); Chugai Pharma (Inst); CrystalGenomics (Inst); IDEAYA Biosciences (Inst); Inmune Bio (Inst); Kronos Bio (Inst); MBrace Therapeutics (Inst); OncoResponse (Inst); Oncternal Therapeutics (Inst); Prelude Therapeutics (Inst); Stemline Therapeutics (Inst); Takeda (Inst); Tarus Therapeutics (Inst)
 
Andrae L. Vandross
No Relationships to Disclose
 
Ecaterina Elena Dumbrava
Consulting or Advisory Role - Bolt Biotherapeutics; Fate Therapeutics; Mersana; PMV Pharma; Summit Therapeutics
Speakers' Bureau - PMV Pharma
Research Funding - A2A Pharmaceuticals (Inst); Aileron Therapeutics (Inst); Amgen (Inst); Aprea Therapeutics (Inst); Astex Pharmaceuticals (Inst); Bayer (Inst); Bellicum Pharmaceuticals (Inst); Boehringer Ingelheim (Inst); Bolt Biotherapeutics (Inst); Compugen (Inst); Dragonfly Therapeutics (Inst); Genentech (Inst); Immunocore (Inst); Immunomedics/Gilead (Inst); Mereo BioPharma 5 (Inst); Mersana (Inst); PMV Pharma (Inst); Poseida (Inst); Rain Therapeutics (Inst); Sanofi (Inst); Seagen (Inst); Soto (Inst); Triumvira Immunologics, Inc (Inst); Volastra Therapeutics (Inst)
Travel, Accommodations, Expenses - Rain Oncology; Triumvira Immunologics, Inc
 
Antonio Giordano
Consulting or Advisory Role - Pfizer; Pfizer
 
Christopher Chen
Consulting or Advisory Role - Boxer Capital; Globepoint Global
Research Funding - ADC Therapeutics (Inst); Gilead Sciences (Inst); Kinnate Biopharma (Inst); Mersana (Inst); ORIC Pharmaceuticals (Inst); Palleon Pharmaceuticals (Inst); Pionyr Therapeutics (Inst); Rain Oncology (Inst); Seagen (Inst); Takeda (Inst)
 
Justin Kenkel
Employment - Bolt Biotherapeutics
 
Danlin Cai
Employment - Bolt Biotherapeutics
 
Lu Xu
Employment - Bolt Biotherapeutics
 
Michael N. Alonso
Employment - Bolt Biotherapeutics
 
Shelley Ackerman
Employment - Bolt Biotherapeutics
 
Tai Yu
Employment - Bolt Biotherapeutics
 
Dawn E. Colburn
Employment - Bolt Biotherapeutics
 
Edith A. Perez
Employment - Bolt Biotherapeutics
 
Sharon Wilks
Speakers' Bureau - IDEOlogy Health